Paediatric transfusion

Related Experiment Video

Updated: Oct 4, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

J Simpson1, S Kinsey

  • 1Yorkshire Regional Centre for Paediatric Oncology & Haematology, St James's University Hospital, Leeds, UK.

Vox Sanguinis
|August 25, 2001
PubMed

Insights

Paediatric transfusion requires special considerations due to developmental changes and maternal antibodies in children. Minimizing transfusion risks is crucial for long-term health outcomes in young patients.

Area of Science:

  • Pediatrics
  • Hematology
  • Transfusion Medicine

Background:

  • Paediatric transfusion presents unique challenges compared to adult transfusion.
  • Children's physiology changes significantly with growth and development.
  • Maternal antibodies and inherited conditions add complexity to paediatric transfusions.

Purpose of the Study:

  • To highlight the distinct considerations in paediatric transfusion.
  • To emphasize the differences between adult and paediatric transfusion recipients.
  • To address the specific challenges in neonates and infants.

Main Methods:

  • Review of clinical circumstances in paediatric transfusion.
  • Analysis of developmental changes impacting transfusion needs.
  • Consideration of maternal antibody effects and inherited conditions.

Main Results:

  • Children are not simply smaller adults; significant physiological differences exist.
  • Neonates present unique challenges due to developmental immaturity and maternally derived antibodies.
  • Intrauterine transfusions introduce further complexity.
  • Long-term consequences of transfusion in children are a significant concern.

Conclusions:

  • Paediatric transfusion necessitates tailored approaches distinct from adult care.
  • Careful management is required to mitigate risks associated with developmental stages and immunological factors.
  • Minimizing transfusion risks is paramount to ensure favourable long-term outcomes for paediatric recipients.

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...